Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, it is still a bit surprising, since the pharmaceutical giant is one of the ...

Square parent Block and Shopify are trading around buy points despite market volatility around big earnings and Trump tariffs ...

A “ cold shock” sounds unpromising, at least at first blush. Plunge into icy water, and, as you gasp for air, your heartbeat ...

As its shares pop in Friday's session, pharmaceutical giant AbbVie Inc. (ABBV) posted a fourth quarter revenue beat and raised its long-term sales guidance for new drugs Skyrizi and Rinvoq by $4 ...

A woman with heart failure was kept alive long enough to receive a heart transplant, in part thanks to newly developed ...

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

HYDERABAD: Osmania General Hospital (OGH) set an exceptional record by performing a liver transplant surgery on a Tyrosinemia ...

Kansas is currently experiencing a large tuberculosis outbreak, but federal health officials are countering the claim it’s a ...

Rapamycin is a drug originally used as an immunosuppressant to prevent organ transplant rejection and as a treatment for some ...

Nobel Laureate Venki Ramakrishnan advocates for healthy lifestyle over anti-ageing drugs, cautioning against dubious ...

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.